Fusarium: Molecular Diversity and Intrinsic Drug Resistance

PLoS Pathogens

Volumn 12, Issue 4, 2016, Pages

  Al Hatmi, Abdullah M S ^a,b,c   Meis, Jacques F ^d,e   de Hoog, G Sybren ^a,b,f,g  

^a CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c MINISTRY OF HEALTH   (Oman)

^d CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^g KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; BROMUCONAZOLE; CASPOFUNGIN; DIFENOCONAZOLE; EPOXICONAZOLE; FLUCYTOSINE; NATAMYCIN; POSACONAZOLE; PROPICONAZOLE; TEBUCONAZOLE; TERBINAFINE; UNCLASSIFIED DRUG; VORICONAZOLE; ANTIFUNGAL AGENT;

ANTIFUNGAL RESISTANCE; BIODIVERSITY; FUSARIOSIS; FUSARIUM; GENETIC VARIABILITY; INCIDENCE; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PREVALENCE; REVIEW; ANIMAL; DRUG EFFECTS; DRUG RESISTANCE; GENETIC VARIATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; PLANT DISEASE;

ANIMALS; ANTIFUNGAL AGENTS; DRUG RESISTANCE; FUSARIUM; GENETIC VARIATION; HUMANS; PLANT DISEASES; PREVALENCE;

EID: 84964895505     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005464     Document Type: Review

References (42)

1. Mikami R, Stemmermann GN, (1958) Keratomycosis caused by Fusarium oxysporum. Am J Clin Pathol29: 257–262. 13520660
2. Nucci M, Varon AG, Garnica M, Akiti T, Barreiros G, et al. (2013) Increased incidence of invasive fusariosis with cutaneous portal of entry, Brazil. Emerg Infect Dis19: 1567–1572. doi: 10.3201/eid1910.12084724050318
3. Oechsler R, Yamanaka T, Bispo PJ, Sartori J, Yu MC, et al. (2013) Fusarium keratitis in Brazil: genotyping, in vitro susceptibilities, and clinical outcomes. Clin Ophthalmol7: 1693–1701. doi: 10.2147/OPTH.S4006324039389
4. Perea S, Patterson TF, (2002) Antifungal resistance in pathogenic fungi. Clin Infect Dis35: 1073–1080. 12384841
5. Musa MO, Al Eisa A, Halim M, Sahovic E, Gyger M, et al. (2000) The spectrum of Fusarium infection in immunocompromised patients with haematological malignancies and in non-immunocompromised patients: a single institution experience over 10 years. Br J Haematol108: 544–548. 10759712
6. Garcia RR, Min Z, Narasimhan S, Bhanot N, (2015) Fusarium brain abscess: case report and literature review. Mycoses58: 22–26.
7. Crabol Y, Lortholary O, (2014) Invasive mold infections in solid organ transplant recipients. Scientifica 2014;2014:821969. doi: 10.1155/2014/82196925525551
8. Engering A, Hogerwerf L, Slingenbergh J, (2013) Pathogen–host–environment interplay and disease emergence. Emerg Microbes Infect2: e5. doi: 10.1038/emi.2013.526038452
9. Nagarajan S, Singh D V, (1990) Long-distance dispersion of rust pathogens. Annu Rev Phytopathol28: 139–153. doi: 10.1146/annurev.py.28.090190.00103520540608
10. Al-Hatmi AMS, Mirabolfathy M, Hagen F, Normand A-C, Stielow JB, et al. (2016) DNA barcoding, MALDI-TOF and AFLP data support Fusarium ficicrescens as a distinct species within the F. fujikuroi species complex. Fungal Biol120:265–278. doi: 10.1016/j.funbio.2015.08.00126781381
11. Wollenweber HW, Reinking OA, (1935) The Fusaria: Their description injurious effects and control. Paul Parey, Berlin8: 1–135
12. Booth C, (1971) The genus Fusarium. Kew. Commonwealth Mycological Institute; p. 237.
13. Leslie JF, Summerell BA, (2006) The Fusarium laboratory manual. (Blackwell Publishing, Ames, IA).
14. Laurence MH, Walsh JL, Shuttleworth LA, Robinson DM, Johansen RM, et al. (2015) Six novel species of Fusarium from natural ecosystems in Australia. Fungal Diversdoi: 10.1007/s13225-015-0337
15. Al-Hatmi AMS, Gerrits van den Ende A. H. G., Stielow JB, van Diepeningen AD, Seifert KA, et al. (2016) Evaluation of two novel barcodes for species recognition of opportunistic pathogens in Fusarium. Fungal Biol120:231–245. doi: 10.1016/j.funbio.2015.08.00626781379
16. de Hoog GS, Guarro J, Gené J, Figueras MJ, 2011. Atlas of Clinical Fungi, 3rd ed.Centraalbureau voor Schimmelcultures, Utrecht, Netherlands.
17. Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, et al. (2012) Hidden killers: human fungal infections. Sci Transl Med4: 165rv13. doi: 10.1126/scitranslmed.300440423253612
18. Smith SN, (2007) An overview of ecological and habitat aspects in the genus Fusarium with special emphasis on the soil-borne pathogenic forms. Plant Pathology Bulletin16: 97–120.
19. Schmale DG, Ross SD, Fetters T, Tallapragada P, Wood-Jones A, et al. (2012) Isolates of Fusarium graminearum collected 40–320 meters above ground level cause Fusarium head blight in wheat and produce trichothecene mycotoxins. Aerobiologia28: 1–11.
20. Lin B, Bozorgmagham AE, Ross S, Schmale DG, (2013) Small fluctuations in the recovery of fusaria across consecutive sampling intervals with unmanned aircraft 100 m above ground level. Aerobiologia29: 45–54.
21. Moretti ML, Busso-Lopes A, Moraes R, Muraosa Y, Mikami Y, et al. (2014) Environment as a potential source of Fusarium spp. invasive infections in immunocompromised patients. Open Forum Infect Dis1 (suppl 1): S38. doi: 10.1093/ofid/ofu051.102
22. Short DPG, O’Donnell K, Zhang N, Juba JH, Geiser DM, (2011) Widespread occurrence of diverse pathogenic types of the fungus Fusarium in bathroom plumbing drains. J Clin Microbiol49: 4264–272. doi: 10.1128/JCM.05468-1121976755
23. Guarro J, (2013) Fusariosis, a complex infection caused by a high diversity of fungal species refractory to treatment. Eur. J Clin Microbiol Infect Dis32:1491–500.
24. Chowdhary A, Kathuria S, Xu J, Sharma C, Sundar G, et al. (2012) Clonal expansion and emergence of environmental multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR34/L98H mutations in the cyp51A gene in India. PLoS ONE. 7:e52871. doi: 10.1371/journal.pone.005287123285210
25. Chowdhary A, Kathuria S, Xu J, Meis JF, (2013) Emergence of azole-resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health. PLoS Pathog9:e1003633. doi: 10.1371/journal.ppat.100363324204249
26. Kretschmer M, Leroch M, Mosbach A, Walker A-S, Fillinger S, et al (2009) Fungicide driven evolution and molecular basis of multidrug resistance in field populations of the grey mould fungus Botrytis cinerea. PLoS Pathog5: e1000696. doi: 10.1371/journal.ppat.100069620019793
27. White TC, Marr KA, Bowden RA, (1998) Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev11: 382–402. 9564569
28. Hawkins NJ, Cools HJ, Sierotzki H, Shaw MW, Knogge W, et al. (2014) Paralog re-emergence: a novel, historically contingent mechanism in the evolution of antimicrobial resistance. Mol Biol Evol31: 1793–1802. doi: 10.1093/molbev/msu13424732957
29. Al-Hatmi AMS, van Diepeningen A, Curfs-Breuker I, de Hoog GS, Meis JF, (2015) Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex. J Antimicrob Chemother70: 1068–1071. doi: 10.1093/jac/dku50525538167
30. Heyn K, Tredup A, Salvenmoser S, Müller FM, (2005) Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani. Antimicrob Agents Chemother49: 5157–5159. 16304192
31. Fan J, Urban M, Parker JE, Brewer HC, Kelly SL, et al. (2013) Characterization of the sterol 14α-demethylases of Fusarium graminearum identifies a novel genus-specific CYP51 function. New Phytol198: 821–835. doi: 10.1111/nph.1219323442154
32. Katiyar SK, Edlind TD, (2009) Role for Fks1 in the intrinsic echinocandin resistance of Fusarium solani as evidenced by hybrid expression in Saccharomyces cerevisiae. Antimicrob Agents Chemother53: 1772–1778. doi: 10.1128/AAC.00020-0919258277
33. Berthiller F, Crews C, Dall’Asta C, Saeger SD, Haesaert G, et al (2013) Masked mycotoxins: a review. Mol Nutr Food Res57: 165–186. doi: 10.1002/mnfr.20110076423047235
34. Stempel JM, Hammond SP, Sutton DA, Weiser LM, Marty FM, . (2015) Invasive fusariosis in the voriconazole era: Single-center 13-year experience. Open Forum Infect Dis.2(3):ofv099. doi: 10.1093/ofid/ofv09926258156
35. Horn DL, Freifeld AG, Schuster MG, Azie NE, Franks B, et al. (2014) Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance registry. Mycoses. 57:652–658. doi: 10.1111/myc.1221224943384
36. Nucci M, Marr KA, Vehreschild MJ, de Souza CA, Velasco E, et al. (2014) Improvement in the outcome of invasive fusariosis in the last decade. Clin Microbiol Infect20: 580–585. doi: 10.1111/1469-0691.1240924118322
37. Tortorano AM, Richardson M, Roilides E, van Diepeningen A, Caira M, et al. (2014) ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect20: Suppl 3:27–46. doi: 10.1111/1469-0691.1246524548001
38. Espinel-Ingroff A, Colombo AL, Cordoba S, Dufresne PJ, Fuller J, et al (2016) An international evaluation of MIC distributions and ECV definition for Fusarium species identified by molecular methods for the CLSI broth microdilution method. Antimicrob Agents Chemother. 60:1079–84. doi: 10.1128/AAC.02456-15
39. Ghannoum M, Isham N, (2014) Fungal nail infections (Onychomycosis): A never-ending story?PLoS Pathog10: doi: 10.1371/journal.ppat.1004105
40. Sharma S, Das S, Virdi A, Fernandes M, Sahu SK, et al (2015) Re-appraisal of topical 1% voriconazole and 5% natamycin in the treatment of fungal keratitis in a randomised trial. Br J Ophthalmol99:1190–1195. doi: 10.1136/bjophthalmol-2014-30648525740805
41. Spader TB, Venturini TP, Rossato L, Denardi LB, Cavalheiro PB, et al. (2013) Synergysm of voriconazole or itraconazole with other antifungal agents against species of Fusarium. Rev Iberoam Micol30: 200–204. doi: 10.1016/j.riam.2013.01.00223402831
42. Al-Hatmi AMS, Meletiadis J, Curfs-Breuker I, Bonifaz A, Meis JF, et al. (2016) In vitro combinations of natamycin with voriconazole, itraconazole and micafungin against clinical Fusarium isolates causing keratitis. J Antimicrob Chemother71: doi: 10.1093/jac/dkv421